Strong Associations Between Early Tubular Damage and Urinary Cytokine, Chemokine, and Growth Factor Levels in Elderly Males and Females.


Journal

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
ISSN: 1557-7465
Titre abrégé: J Interferon Cytokine Res
Pays: United States
ID NLM: 9507088

Informations de publication

Date de publication:
08 2021
Historique:
entrez: 19 8 2021
pubmed: 20 8 2021
medline: 2 2 2022
Statut: ppublish

Résumé

Acute tubular necrosis is associated with high mortality rates and it is important to develop new biomarkers for tubular damage. The aim of this study was to investigate the effect of early tubular damage on a large number of urinary cytokines, chemokines, and growth factors. We selected 90 urine samples from the Prospective Investigation of the Vasculature in Uppsala Seniors Study (41 males and 49 females). The tubular damage markers cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) were analyzed in the urine samples and urinary cytokine levels were analyzed with 2 multiplex assays (proximity extension assay). After adjustment for sex, body mass index, estimated glomerular filtration rate, smoking, and multiplicity testing using the false discovery rate approach, there remained 26 cytokines that correlated significantly with urine cystatin C, 27 cytokines that correlated with NGAL, and 66 cytokines that correlated with KIM-1. Tubular damage shows a strong association with urinary cytokines, chemokines, and growth factors. Our findings indicate that multiplex proteomics could be a promising new approach to explore the complex effects of tubular damage.

Identifiants

pubmed: 34410878
doi: 10.1089/jir.2021.0065
doi:

Substances chimiques

Chemokines 0
Cytokines 0
Intercellular Signaling Peptides and Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-290

Auteurs

Bengt Fellström (B)

Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.

Johanna Helmersson-Karlqvist (J)

Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.

Lars Lind (L)

Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.

Inga Soveri (I)

Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.

Måns Thulin (M)

Centre for Statistics, The Swedish University of Agricultural Sciences, Uppsala, Sweden.

Johan Ärnlöv (J)

Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden.

Kim Kultima (K)

Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.

Anders Larsson (A)

Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH